{"id":61132,"date":"2025-09-26T20:54:14","date_gmt":"2025-09-26T18:54:14","guid":{"rendered":"https:\/\/carlosoconnor.es\/?p=61132"},"modified":"2025-09-29T17:26:56","modified_gmt":"2025-09-29T15:26:56","slug":"ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos","status":"publish","type":"post","link":"https:\/\/carlosoconnor.es\/en\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/","title":{"rendered":"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS"},"content":{"rendered":"

Les comparto una investigaci\u00f3n que busca revisar y sintetizar en la literatura actual de ensayos cl\u00ednicos los que investigaron la eficacia y seguridad de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 (ARGLP-1) en personas con apnea obstructiva del sue\u00f1o (AOS).<\/p>\n\n\n\n

——————————-<\/p>\n\n\n\n

I am sharing a study that seeks to review and synthesize current clinical trial literature investigating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in people with obstructive sleep apnea (OSA).<\/p>\n\n\n\n

Enlace\/Link: https:\/\/www.mdpi.com\/2673-5318\/6\/3\/111<\/p>\n\n\n\n

\"MixCollage
MixCollage 26 Sep 2025 01 51 PM 1289<\/figcaption><\/figure>","protected":false},"excerpt":{"rendered":"

Les comparto una investigaci\u00f3n que busca revisar y sintetizar en la literatura actual de ensayos cl\u00ednicos los que investigaron la eficacia y seguridad de los agonistas del receptor del p\u00e9ptido…<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[270],"tags":[],"class_list":["post-61132","post","type-post","status-publish","format-standard","hentry","category-apnea-obstructiva-del-sueno"],"yoast_head":"\nEnsayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS - Carlos O'Connor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/carlosoconnor.es\/en\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS - Carlos O'Connor\" \/>\n<meta property=\"og:description\" content=\"Les comparto una investigaci\u00f3n que busca revisar y sintetizar en la literatura actual de ensayos cl\u00ednicos los que investigaron la eficacia y seguridad de los agonistas del receptor del p\u00e9ptido…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/carlosoconnor.es\/en\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/\" \/>\n<meta property=\"og:site_name\" content=\"Carlos O'Connor\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-26T18:54:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-29T15:26:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"gestion\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"gestion\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/\"},\"author\":{\"name\":\"gestion\",\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949\"},\"headline\":\"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS\",\"datePublished\":\"2025-09-26T18:54:14+00:00\",\"dateModified\":\"2025-09-29T15:26:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/\"},\"wordCount\":111,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/carlosoconnor.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-1024x1024.jpg\",\"articleSection\":[\"Apnea obstructiva del sue\u00f1o\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/\",\"url\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/\",\"name\":\"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS - Carlos O'Connor\",\"isPartOf\":{\"@id\":\"https:\/\/carlosoconnor.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-1024x1024.jpg\",\"datePublished\":\"2025-09-26T18:54:14+00:00\",\"dateModified\":\"2025-09-29T15:26:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#primaryimage\",\"url\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-1024x1024.jpg\",\"contentUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-1024x1024.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/carlosoconnor.es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/carlosoconnor.es\/#website\",\"url\":\"https:\/\/carlosoconnor.es\/\",\"name\":\"Carlos O'Connor\",\"description\":\"Dr. Carlos O'Connor Reina - Otorrinolaring\u00f3logo\",\"publisher\":{\"@id\":\"https:\/\/carlosoconnor.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/carlosoconnor.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/carlosoconnor.es\/#organization\",\"name\":\"Carlos O'Connor\",\"url\":\"https:\/\/carlosoconnor.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png\",\"contentUrl\":\"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png\",\"width\":241,\"height\":50,\"caption\":\"Carlos O'Connor\"},\"image\":{\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949\",\"name\":\"gestion\",\"sameAs\":[\"https:\/\/www.ycomieronperdices.net\/temp\/oconnor2025\"],\"url\":\"https:\/\/carlosoconnor.es\/en\/author\/gestion\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS - Carlos O'Connor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/carlosoconnor.es\/en\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/","og_locale":"en_GB","og_type":"article","og_title":"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS - Carlos O'Connor","og_description":"Les comparto una investigaci\u00f3n que busca revisar y sintetizar en la literatura actual de ensayos cl\u00ednicos los que investigaron la eficacia y seguridad de los agonistas del receptor del p\u00e9ptido…","og_url":"https:\/\/carlosoconnor.es\/en\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/","og_site_name":"Carlos O'Connor","article_published_time":"2025-09-26T18:54:14+00:00","article_modified_time":"2025-09-29T15:26:56+00:00","og_image":[{"width":2560,"height":2560,"url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-scaled.jpg","type":"image\/jpeg"}],"author":"gestion","twitter_card":"summary_large_image","twitter_misc":{"Written by":"gestion"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#article","isPartOf":{"@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/"},"author":{"name":"gestion","@id":"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949"},"headline":"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS","datePublished":"2025-09-26T18:54:14+00:00","dateModified":"2025-09-29T15:26:56+00:00","mainEntityOfPage":{"@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/"},"wordCount":111,"commentCount":0,"publisher":{"@id":"https:\/\/carlosoconnor.es\/#organization"},"image":{"@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#primaryimage"},"thumbnailUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-1024x1024.jpg","articleSection":["Apnea obstructiva del sue\u00f1o"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/","url":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/","name":"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS - Carlos O'Connor","isPartOf":{"@id":"https:\/\/carlosoconnor.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#primaryimage"},"image":{"@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#primaryimage"},"thumbnailUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-1024x1024.jpg","datePublished":"2025-09-26T18:54:14+00:00","dateModified":"2025-09-29T15:26:56+00:00","breadcrumb":{"@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#primaryimage","url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-1024x1024.jpg","contentUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/09\/MixCollage-26-Sep-2025-01-51-PM-1289-1024x1024.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/carlosoconnor.es\/ensayos-clinicos-de-los-agonistas-del-receptor-del-peptido-similar-al-glucagon-1-en-pacientes-con-aos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/carlosoconnor.es\/"},{"@type":"ListItem","position":2,"name":"Ensayos cl\u00ednicos de los agonistas del receptor del p\u00e9ptido similar al glucag\u00f3n-1 en pacientes con AOS"}]},{"@type":"WebSite","@id":"https:\/\/carlosoconnor.es\/#website","url":"https:\/\/carlosoconnor.es\/","name":"Carlos O'Connor","description":"Dr. Carlos O'Connor Reina - Otorrinolaring\u00f3logo","publisher":{"@id":"https:\/\/carlosoconnor.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/carlosoconnor.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/carlosoconnor.es\/#organization","name":"Carlos O'Connor","url":"https:\/\/carlosoconnor.es\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/","url":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png","contentUrl":"https:\/\/carlosoconnor.es\/wp-content\/uploads\/2025\/07\/cropped-logo-wide.png","width":241,"height":50,"caption":"Carlos O'Connor"},"image":{"@id":"https:\/\/carlosoconnor.es\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/carlosoconnor.es\/#\/schema\/person\/c879dbc2b732eaa32429f50dfbd0a949","name":"gestion","sameAs":["https:\/\/www.ycomieronperdices.net\/temp\/oconnor2025"],"url":"https:\/\/carlosoconnor.es\/en\/author\/gestion\/"}]}},"_links":{"self":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/61132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/comments?post=61132"}],"version-history":[{"count":1,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/61132\/revisions"}],"predecessor-version":[{"id":61134,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/posts\/61132\/revisions\/61134"}],"wp:attachment":[{"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/media?parent=61132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/categories?post=61132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/carlosoconnor.es\/en\/wp-json\/wp\/v2\/tags?post=61132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}